Synergistic effect of ponatinib and epigallocatechin-3-gallate induces apoptosis in chronic myeloid leukemia cells through altering expressions of cell cycle regulatory genes.
Makaleler > Tam Makale · 2014
Yazarlar: BAKİYE GOKER, Cansu CALISKAN, Hasan Onur CAGLAR, Cagla KAYABASI, Tugce BALCI, Burcu Erbaykent Tepedelen, Duygu Döndü AYGÜNEŞ JAFARI, Sunde YILMAZ SÜSLÜER, Zeynep MUTLU, Nur Selvi GUNEL, Mehmet Korkmaz, Güray SAYDAM, Cumhur GÜNDÜZ, Çığır BİRAY AVCI
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2014, cilt 19, ss 992-8
Özet
Purpose: Ponatinib (P) has been used for the treatment of chronic myeloid leukemia (CML) and it is known that inhibition of BCR-ABL fusion protein by ponatinib induces apoptosis of CML cells. Epigallocatechin-3-gallate (EGCG), which is a poly phenol in green tea, induces apoptosis in different types of cancer cells. The purpose of this study was to determine the cytotoxic and apoptotic effects of ponatinib and EGCG combination in K562 CML cell line. This study also aimed to detect alterations of the expression levels of cell cycle-regulation related genes after ponatinib and EGCG combination in K562 CML cell line.